Articles with "target neurodegenerative" as a keyword



Photo from wikipedia

Progranulin as a therapeutic target in neurodegenerative diseases.

Sign Up to like & get
recommendations!
Published in 2022 at "Trends in pharmacological sciences"

DOI: 10.1016/j.tips.2021.11.015

Abstract: Progranulin (PGRN, encoded by the GRN gene) plays a key role in the development, survival, function, and maintenance of neurons and microglia in the mammalian brain. It regulates lysosomal biogenesis, inflammation, repair, stress response, and… read more here.

Keywords: progranulin therapeutic; target neurodegenerative; pgrn; gene ... See more keywords
Photo from wikipedia

The case for complement component 5 as a target in neurodegenerative disease

Sign Up to like & get
recommendations!
Published in 2023 at "Expert Opinion on Therapeutic Targets"

DOI: 10.1080/14728222.2023.2177532

Abstract: ABSTRACT Introduction Complement-based drug discovery is undergoing a renaissance, empowered by new advances in structural biology, complement biology and drug development. Certain components of the complement pathway, particularly C1q and C3, have been extensively studied… read more here.

Keywords: disease; case complement; neurodegenerative disease; target neurodegenerative ... See more keywords